First-in-line subcutaneous injectable for reversible, non-hormonal male contraception

Sarah Anne Howard, James K. Tsuruta, Andres Prieto Trujillo, Roopali Shrivastava, Ava Cohen, Rani S. Sellers, Katherine G. Hamil, Michael G. O’Rand, S. Rahima Benhabbour

Open source

DOI: 10.1007/s13346-025-01871-3
Published: 2025-05-27
Container: Drug Delivery and Translational Research
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s13346-025-01871-3,
  title = {First-in-line subcutaneous injectable for reversible, non-hormonal male contraception},
  author = {Sarah Anne Howard and James K. Tsuruta and Andres Prieto Trujillo and Roopali Shrivastava and Ava Cohen and Rani S. Sellers and Katherine G. Hamil and Michael G. O’Rand and S. Rahima Benhabbour},
  year = {2025},
  journal = {Drug Delivery and Translational Research},
  doi = {10.1007/s13346-025-01871-3},
  url = {https://doi.org/10.1007/s13346-025-01871-3}
}

RIS

TY  - JOUR
TI  - First-in-line subcutaneous injectable for reversible, non-hormonal male contraception
AU  - Sarah Anne Howard
AU  - James K. Tsuruta
AU  - Andres Prieto Trujillo
AU  - Roopali Shrivastava
AU  - Ava Cohen
AU  - Rani S. Sellers
AU  - Katherine G. Hamil
AU  - Michael G. O’Rand
AU  - S. Rahima Benhabbour
PY  - 2025
JO  - Drug Delivery and Translational Research
DO  - 10.1007/s13346-025-01871-3
UR  - https://doi.org/10.1007/s13346-025-01871-3
ER  -

APA

Howard, S. A., Tsuruta, J. K., Trujillo, A. P., Shrivastava, R., Cohen, A., Sellers, R. S., Hamil, K. G., O’Rand, M. G., & Benhabbour, S. R. (2025). First-in-line subcutaneous injectable for reversible, non-hormonal male contraception. Drug Delivery and Translational Research. https://doi.org/10.1007/s13346-025-01871-3

Source records

crossref · retrieved 2026-09-27T00:19:26.395Z